[1]
M. Mirzaei, A. Daneshpajooh, S. O. Anvari, S. Dozchizadeh, and M. Teimorian, “Evaluation of the Clinical Efficacy and Complications of Duloxetine in Comparison to Solifenacin in the Treatment of Overactive Bladder Disease in Women: A Randomized Clinical Trial”, Urol J, vol. 18, no. 05, pp. 543–548, Aug. 2021.